Back to search

Design considerations for tumour-targeted nanoparticles

Data up to Jan 2025

Published2009
Citations712
References30

Total Citations Per Year

Abstract

References (30)

Nanocarriers as an emerging platform for cancer therapy

2007 • 8,023 citations

Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics

2005 • 7,550 citations

Quantum dot bioconjugates for imaging, labelling and sensing

2005 • 5,951 citations

In vivo cancer targeting and imaging with semiconductor quantum dots

2004 • 4,633 citations

Renal clearance of quantum dots

2007 • 4,071 citations

Nanoparticle therapeutics: an emerging treatment modality for cancer

2008 • 3,976 citations

The use of nanocrystals in biological detection

2003 • 2,970 citations

The potential environmental impact of engineered nanomaterials

2003 • 2,146 citations

In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags

2007 • 2,112 citations

Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer

2003 • 1,965 citations

Polymer conjugates as anticancer nanomedicines

2006 • 1,894 citations

Immunological properties of engineered nanomaterials

2007 • 1,638 citations

Bioconjugated quantum dots for in vivo molecular and cellular imaging☆

2008 • 1,122 citations

Peptide-Labeled Near-Infrared Quantum Dots for Imaging Tumor Vasculature in Living Subjects

2006 • 931 citations

Cell-specific targeting of nanoparticles by multivalent attachment of small molecules

2005 • 895 citations

New Technologies for Human Cancer Imaging

2008 • 741 citations

Compact Cysteine-Coated CdSe(ZnCdS) Quantum Dots for in Vivo Applications

2007 • 401 citations

Sentinel Lymph Node Imaging Using Quantum Dots in Mouse Tumor Models

2007 • 335 citations

Tissue- and Organ-Selective Biodistribution of NIR Fluorescent Quantum Dots

2009 • 294 citations

Image-Guided Oncologic Surgery Using Invisible Light: Completed Pre-Clinical Development for Sentinel Lymph Node Mapping

2006 • 251 citations

Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process

2008 • 244 citations

Development of aliphatic biodegradable photoluminescent polymers

2009 • 220 citations

Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots

2008 • 199 citations

Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation

2004 • 198 citations

Quantum Dots for In Vivo Small-Animal Imaging

2009 • 190 citations

High-affinity Near-infrared Fluorescent Small-molecule Contrast Agents for In Vivo Imaging of Prostate-specific Membrane Antigen

2005 • 86 citations

Liver Function Assessment by Drug Metabolism

1990 • 50 citations

Translating in vivo diagnostics into clinical reality

2006 • 43 citations

[General mechanism of intratumor accumulation of macromolecules: advantage of macromolecular therapeutics].

1987 • 39 citations

Technetium-99m DADS complexes as renal function and imaging agents: II. Biological comparison with iodine-131 hippuran.

1985 • 19 citations

Cited By (0)

No citing papers found in database

Design considerations for tumour-targeted nanoparticles (2009) – Nature Nanotechnology | Metascience Observatory Explorer